BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2021 9:58:01 AM | Browse: 644 | Download: 1575
 |
Received |
|
2021-01-13 18:33 |
|
Peer-Review Started |
|
2021-01-13 18:34 |
|
First Decision by Editorial Office Director |
|
2021-02-10 23:30 |
|
Return for Revision |
|
2021-02-13 08:24 |
|
Revised |
|
2021-02-24 21:36 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-04-26 10:06 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-04-26 10:27 |
|
Articles in Press |
|
2021-04-26 10:27 |
|
Edit the Manuscript by Language Editor |
|
2021-05-05 11:25 |
|
Typeset the Manuscript |
|
2021-05-20 13:19 |
|
Publish the Manuscript Online |
|
2021-05-26 09:58 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Non-alcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Musaab Ahmed and Mohamed H Ahmed |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed H Ahmed, MBBS, PhD, Doctor, Doctor, Department of Medicine and HIV metabolic clinic, Milton Keynes University Hospital NHS Foundation Trust, Eaglestone, Milton Keynes MK5 6LD, United Kingdom. mohamed.hassan-ahmed@mkuh.nhs.uk |
| Key Words |
Fatty liver; COVID-19; Diabetes; Obesity and pandemic |
| Core Tip |
The earlier studies suggested that most vulnerable individuals to severe acute respiratory syndrome coronavirus 2 infection suffer from pre-existing disease, including non-alcoholic fatty liver disease (NAFLD). There is an interwoven relationship between NAFLD and the associated high-risk factors for coronavirus disease 2019 (COVID-19). NAFLD can increase risk of infection, lung injury, cardiac impairment and difficulty with respiratory ventilation and can be associated with higher risk for COVID-19 especially in presence of liver fibrosis. The association between high production of interleukin- 6 in both NAFLD and COVID-19 may raise the need for further research in whether NAFLD can directly be involved in the cytokine storms. |
| Publish Date |
2021-05-26 09:58 |
| Citation |
Ahmed M, Ahmed MH. Non-alcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic. World J Clin Cases 2021; 9(17): 4133-4142 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i17/4133.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i17.4133 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
